Microba Life Sciences Limited
MAP
Rank in Stocks
#26953
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Share Price
$0.02353446
Last synced: 2026-11-09
Market Cap
$17.48M
Change (1 day)
-8.27%
Change (1 year)
-54.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Microba Life Sciences Limited (MAP)
Category
Healthcare
Operating Margin for Microba Life Sciences Limited (MAP)
Operating Margin as of November 2026 TTM: -137.58%
According to Microba Life Sciences Limited's latest financial reports, its current operating margin (TTM) is -137.58%. At the end of 2025 the company had an operating margin of -157.05%.
Operating Margin history for Microba Life Sciences Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -137.58% | -12.40% |
| 2025 | -157.05% | -29.26% |
| 2024 | -222.02% | -40.51% |
| 2023 | -373.18% | 7.53% |
| 2022 | -347.05% | 35.35% |
| 2021 | -256.41% | 0.71% |
| 2020 | -254.59% | -2.81% |
| 2019 | -261.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.13% |
US
|
|
| 20.38% | -100.15% |
US
|
|
| 43.02% | -100.31% |
CN
|
|
| 32.03% | -100.23% |
US
|
|
| 22.23% | -100.16% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Microba Life Sciences Limited's operating margin
What is Microba Life Sciences Limited's operating margin?
Microba Life Sciences Limited's operating margin is -137.58%, as of Nov 2026.
What was Microba Life Sciences Limited's operating margin in 2025?
In 2025, Microba Life Sciences Limited's operating margin was -157.05%, compared with -222.02% in 2024.
How has Microba Life Sciences Limited's operating margin changed since 2020?
From 2020 to 2025, Microba Life Sciences Limited's operating margin was highest in 2025 (-157.05%) and lowest in 2023 (-373.18%).
How does Microba Life Sciences Limited's operating margin compare with similar companies?
Microba Life Sciences Limited's operating margin (-137.58%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.